Throughout National Nurses Month, 4 cancer therapies were given FDA regular or accelerated approval, spanning diseases including ovarian, head and neck, lung, and anal cancers. These treatments will ...

Survival impact of lymphocytopenia during chemoradiation in locally advanced NSCLC patients treated with adjuvant durvalumab. Enhancing early detection of lung cancer: Methylation anchor probe for low ...

Objectives Long-term use of high-dose glucocorticoids can lead to severe immunosuppression and increased risk of treatment-resistant pneumonia and mortality. We investigated the aetiology and ...

The FDA has granted accelerated approval to avutometinib (VS-6766) plus defactinib (VS-6063) for the treatment of adult patients with KRAS-mutated recurrent, low-grade serous ovarian cancer (LGSOC) ...

Stroke-associated immunosuppression is an increasingly recognized factor triggering infections and thus potentially influencing outcome after stroke. Specifically, lymphocytopenia after intracerebral ...

Selenoproteins play a crucial role in protecting blood-forming stem cells from oxidative damage. A study in Blood found that disrupting selenoprotein production impairs immune cell development and ...

Researchers find that certain antioxidant enzymes, called selenoproteins, significantly contribute to fighting cell aging. The team used a gene knockout mouse model to help them study the effects of ...

LPX-TI641 is an oral novel Treg-expanding T cell/transmembrane, immunoglobulin, and mucin (Tim)receptor agonist therapy in development for the treatment of autoimmune diseases such as rheumatoid ...

Please provide your email address to receive an email when new articles are posted on . Systemic corticosteroids can lead to CD4 lymphopenia and lower IgG levels. Rituximab therapy can lead to ...

1. In this observational study, idiopathic CD4 lymphocytopenia (ICL) was associated with an increased risk of opportunistic infections, malignancy, and poor response to coronavirus disease 2019 (COVID ...

THURSDAY, May 4, 2023 (HealthDay News) — Idiopathic CD4 lymphocytopenia (ICL) is associated with increased risk for opportunistic infection and invasive cancer, according to a study published in the ...

National Institutes of Health researchers shared new details about idiopathic CD4 lymphocytopenia (ICL), a rare immune deficiency that leaves people vulnerable to infectious diseases, autoimmune ...